Published in Eye (Lond) on January 20, 2017
Pemphigus. Medicine (Baltimore) (1953) 2.78
Rituximab for patients with refractory mucous membrane pemphigoid. Arch Dermatol (2011) 2.19
Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes. Ophthalmology (2007) 2.17
The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol (2002) 2.10
Cicatricial pemphigoid. Trans Am Ophthalmol Soc (1986) 2.10
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis (2011) 1.88
The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol (2007) 1.66
Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea (1991) 1.65
Trachoma. Lancet (2014) 1.57
Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management. Cornea (2012) 1.56
Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects. Arch Dermatol (2010) 1.52
Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid. Ophthalmology (1995) 1.48
Regulatory B cells: origin, phenotype, and function. Immunity (2015) 1.47
Pemphigoid diseases. Lancet (2012) 1.47
Ocular rosacea: patient characteristics and follow-up. Ophthalmology (1997) 1.43
Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect Immun (2004) 1.41
[Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid]. Klin Monbl Augenheilkd (2001) 1.40
Paraneoplastic conjunctival cicatrization: two different pathogenic types. Ophthalmology (2010) 1.39
Ocular cicatricial pemphigoid. Ophthalmology (1981) 1.38
Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology (1980) 1.35
Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis (2004) 1.33
Corneal toxicity: the epithelium and stroma in iatrogenic and factitious disease. Eye (Lond) (2003) 1.32
Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol (1983) 1.29
The clinical phenotype of trachomatous trichiasis in Ethiopia: not all trichiasis is due to entropion. Invest Ophthalmol Vis Sci (2011) 1.26
Benign mucous membrane pemphigoid. Arch Dermatol (1971) 1.24
Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue. Drugs Aging (2011) 1.23
The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment. Ophthalmology (1979) 1.22
Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology (1982) 1.19
Atopic keratoconjunctivitis. Ophthalmology (1990) 1.18
An outbreak of adenovirus keratoconjunctivitis in bristol. Br J Ophthalmol (1979) 1.17
Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response. Sci Transl Med (2013) 1.15
Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy. Ophthalmology (2008) 1.14
Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci (2003) 1.14
Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology (2004) 1.11
Cicatricial pemphigoid and erythema multiforme. Ophthalmology (1990) 1.10
Lichen planus and cicatrizing conjunctivitis: characterization of five cases. Am J Ophthalmol (2003) 1.09
Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. Ophthalmology (1991) 1.05
The conjunctiva in acute and chronic mucous membrane pemphigoid. An immunohistochemical analysis. Ophthalmology (1993) 1.05
Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br J Dermatol (1989) 1.05
Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis (2012) 1.03
Ocular mucous membrane pemphigoid: diagnosis and management strategies. Ocul Surf (2008) 1.03
Pathway-focused arrays reveal increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis. Invest Ophthalmol Vis Sci (2010) 1.02
Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol (1996) 1.02
Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. Invest Ophthalmol Vis Sci (2011) 1.01
Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol (1982) 1.01
Atopic keratoconjunctivitis and atopic dermatitis. Curr Opin Allergy Clin Immunol (2010) 1.01
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest (1998) 1.00
Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. ScientificWorldJournal (2014) 1.00
Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea (1993) 1.00
Ocular graft-versus-host disease: a review. Surv Ophthalmol (2013) 1.00
Symblepharon formation in epidemic keratoconjunctivitis. Cornea (1990) 0.99
B cells as effectors and regulators of autoimmunity. Autoimmunity (2012) 0.99
Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome. JAMA (1991) 0.98
Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United Kingdom. Eye (Lond) (2011) 0.98
Profibrotic phenotype of conjunctival fibroblasts from mucous membrane pemphigoid. Am J Pathol (2010) 0.97
Cicatricial pemphigoid (mucous membrane pemphigoid): current and emerging therapeutic approaches. Am J Clin Dermatol (2005) 0.97
Cicatrizing conjunctivitis. Trans Ophthalmol Soc U K (1986) 0.96
Porphyria cutanea tarda presenting as cicatricial conjunctivitis. Am J Ophthalmol (2002) 0.96
Treatment of ocular inflammatory disorders with daclizumab. Ophthalmology (2003) 0.96
Association of autoimmunity and cicatricial pemphigoid: is there an immunogenetic basis? J Am Acad Dermatol (1991) 0.96
Diagnosis and classification of autoimmune blistering diseases. Autoimmun Rev (2014) 0.95
Ocular cicatricial pemphigoid: manifestations and management. Curr Allergy Asthma Rep (2005) 0.94
Long-term follow-up of patients with atopic keratoconjunctivitis. Ophthalmology (1998) 0.93
Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report. Ophthalmology (2010) 0.93
Conjunctival fibrosis in ocular cicatricial pemphigoid--the role of cytokines. Exp Eye Res (1997) 0.92
Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci (2003) 0.91
Conjunctival interleukin-13 expression in mucous membrane pemphigoid and functional effects of interleukin-13 on conjunctival fibroblasts in vitro. Am J Pathol (2009) 0.90
Conjunctival biopsy in the diagnosis of sarcoidosis. Br J Ophthalmol (1990) 0.90
Evaluation of mucous membrane pemphigoid with ocular involvement in young patients. Ophthalmology (2005) 0.90
Pathogenesis of mucous membrane pemphigoid. Dermatol Clin (2011) 0.90
Treatment of ocular cicatricial pemphigoid with sulfasalazine. Ophthalmology (2001) 0.90
Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current management. Semin Ophthalmol (2011) 0.89
The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology (2002) 0.89
Cytokines in the conjunctiva of acute and chronic mucous membrane pemphigoid: an immunohistochemical analysis. Graefes Arch Clin Exp Ophthalmol (1993) 0.88
Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology (1989) 0.88
Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid. Ophthalmology (2013) 0.87
Ocular rosacea. Ocul Surf (2005) 0.87
Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review. Br J Dermatol (2002) 0.87
Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients. Arch Dermatol (2006) 0.87
The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation. Graefes Arch Clin Exp Ophthalmol (1994) 0.87
Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid. Br J Ophthalmol (1995) 0.87
Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int Arch Allergy Immunol (2000) 0.87
Role of enhanced expression of m-CSF in conjunctiva affected by cicatricial pemphigoid. Invest Ophthalmol Vis Sci (2002) 0.86
Immunofluorescent studies in ocular cicatricial pemphigoid. Br J Dermatol (1988) 0.86
Chronic bullous dermatoses in China. Int J Dermatol (1993) 0.85
Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity (2011) 0.84
Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients. J Eur Acad Dermatol Venereol (2010) 0.84
Malignancies and cyclophosphamide exposure in Wegener's granulomatosis. J Rheumatol (2008) 0.84
Ocular cicatricial pemphigoid. Ophthalmology (2008) 0.84
Eyelid skin involvement in pemphigus foliaceus. Ocul Immunol Inflamm (2006) 0.84
Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab. Acta Derm Venereol (2009) 0.84
Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab. J Drugs Dermatol (2007) 0.84
Successful treatment of mucous membrane pemphigoid with infliximab. Arch Dermatol (2006) 0.83
Current medical treatment of ocular mucous membrane pemphigoid. Ocul Surf (2013) 0.83
The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement. Br J Ophthalmol (2009) 0.82
Methotrexate therapy for ocular cicatricial pemphigoid. Ophthalmology (2004) 0.82
Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom. Eye (Lond) (2012) 0.82
Natural antibodies in health and disease: an overview of the first international workshop on natural antibodies in health and disease. Autoimmun Rev (2008) 0.82
Rituximab preserves vision in ocular mucous membrane pemphigoid. Expert Opin Biol Ther (2015) 0.81
Tumor necrosis factor-alpha in ocular mucous membrane pemphigoid and its effect on conjunctival fibroblasts. Invest Ophthalmol Vis Sci (2009) 0.81